These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7056279)

  • 1. The pharmacokinetics of diclofenac sodium in patients with active rheumatoid disease.
    Crook PR; Willis JV; Kendall MJ; Jack DB; Fowler PD
    Eur J Clin Pharmacol; 1982; 21(4):331-4. PubMed ID: 7056279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of diclofenac sodium following intravenous and oral administration.
    Willis JV; Kendall MJ; Flinn RM; Thornhill DP; Welling PG
    Eur J Clin Pharmacol; 1979; 16(6):405-10. PubMed ID: 527637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diclofenac sodium: blood concentration of the slow-release form and influence on the metabolism of kallikrein.
    Gross W; Kroh J; Krebs A; Zöller H
    Arzneimittelforschung; 1984; 34(10):1327-9. PubMed ID: 6335038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability of two enteric-coated tablet preparations of diclofenac sodium.
    Paton DM
    Int J Clin Pharmacol Res; 1987; 7(4):239-42. PubMed ID: 3596865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the effect of aspirin on the pharmacokinetics of oral and intravenous diclofenac sodium.
    Willis JV; Kendall MJ; Jack DB
    Eur J Clin Pharmacol; 1980 Nov; 18(5):415-8. PubMed ID: 7439264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of diclofenac and five metabolites after single doses in healthy volunteers and after repeated doses in patients.
    Degen PH; Dieterle W; Schneider W; Theobald W; Sinterhauf U
    Xenobiotica; 1988 Dec; 18(12):1449-55. PubMed ID: 3245235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetics of the new Russian prolonged-action form of diclofenac sodium--Ortopek--in a single oral dose].
    Kurapov AP; Starodubtsev AK; Rubtsova TM; Ignat'ev VG; Kemenova VA
    Eksp Klin Farmakol; 1995; 58(1):53-4. PubMed ID: 7787700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic studies in healthy volunteers on a new gastroprotective pharmaceutic form of diclofenac.
    De Bernardi di Valserra M; Feletti F; Tripodi AS; Contos S; Carabelli A; Maggi L; Germogli R
    Arzneimittelforschung; 1993 Mar; 43(3):373-7. PubMed ID: 8489569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of food on the absorption of diclofenac after single and multiple oral doses.
    Willis JV; Kendall MJ; Jack DB
    Eur J Clin Pharmacol; 1981 Jan; 19(1):33-7. PubMed ID: 7461021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and synovial fluid concentrations of diclofenac sodium and its hydroxylated metabolites during once-daily administration of a 100 mg slow-release formulation.
    Fowler PD; Dawes PT; John VA; Shotton PA
    Eur J Clin Pharmacol; 1986; 31(4):469-72. PubMed ID: 3469101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of slow release diclofenac (Voveran SR) with enteric coated tablet and internationally used Voltaren Retard.
    Sahajwalla CG; Bhatt AD; Bhatia SC; Bakshi R; Doshi KJ; Banavalikar MM; Bharucha ED; Marthak KV; Shah NN; Gupta KC
    J Assoc Physicians India; 1991 Jul; 39(7):546-8. PubMed ID: 1800501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
    Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
    Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics and biological availability of diclofenac preparations following intramuscular injection of 75 mg and oral administration of 150 mg of active drug].
    Kurowski M
    Z Rheumatol; 1988; 47(1):37-42. PubMed ID: 3369245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative bioavailability and pharmacokinetics of Dolotren retard and Dolotren].
    Honorato J; Montes B; Suárez J; Lucero ML; Valiente R
    Rev Med Univ Navarra; 1992; 37(1):7-16. PubMed ID: 1626168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the pharmacokinetics of diclofenac sodium (Voltarol).
    Kendall MJ; Thornhill DP; Willis JV
    Rheumatol Rehabil; 1979; Suppl 2():38-46. PubMed ID: 531447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac.
    Manvelian G; Daniels S; Gibofsky A
    Postgrad Med; 2012 Jan; 124(1):117-23. PubMed ID: 22314121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of diclofenac sodium in normal man.
    Hasan SM; Ahmed T; Talib N; Hasan F
    Pak J Pharm Sci; 2005 Jan; 18(1):18-24. PubMed ID: 16431378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of juvenile rheumatoid arthritis with diclofenac sodium.
    Haapasaari J; Wuolijoki E; Ylijoki H
    Scand J Rheumatol; 1983; 12(4):325-30. PubMed ID: 6361986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical profile of diclofenac-misoprostol combination tablet, Arthrotec.
    Karim A; Smith M
    Scand J Rheumatol Suppl; 1992; 96():37-48. PubMed ID: 1439623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.